Donor Assessment and Management System for Maximizing Heart Availability in Japan

Main Article Content

Norihide Fukushima


As donor shortage is extremely severe in Japan because of the very strict Organ Transplantation Act, special strategies for maximizing organ transplant opportunities should be established. Since November in 2002, special transplant management doctors were sent to donor hospitals in order to assess donor’s organ function and to identify which organ could be transplanted. They also intensively cared for the donor to stabilize hemodynamics and to improve cardiac and lung function by intravenously giving anti-diuretic hormone and pulmonary toileting by broncho-fiberscope. Out of a consecutive 384 brain dead donors, 284 (74.0%) donor hearts were transplanted and the patient survival after heart transplantation at 5, 10 and 15 years were 92.7, 89.6 and 81.8 %, respectively in Japan. These strategies may increase heart availability and improve post-transplant outcomes.

Article Details

How to Cite
FUKUSHIMA, Norihide. Donor Assessment and Management System for Maximizing Heart Availability in Japan. Medical Research Archives, [S.l.], v. 5, n. 12, dec. 2017. ISSN 2375-1924. Available at: <>. Date accessed: 02 mar. 2024. doi:
Research Articles


[1] Fukushima N. Revised Organ Transplant Act and Transplant Surgeons. Jpn Med Assoc J 2011:54(6);387-391
[2] Fukushima N, Ono M, Nakatani T, et al. Transplant Proc. Strategies for maximizing heart and lung transplantation opportunities in Japan 2009; 41(1):273-6.
[3] Novitzky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation. 82(11):1396-401, 2006.
[4] Mascia L, Mastromauro I, Viverti S, et al. Management of optimize organ procurement in brain dead donors. Minerva Anesthesiol 75: 125-33, 2009.
[5] Wood KE, Becker BN, McCartney, et al. Current concepts: Care of potential organ dono. N Engl J Med 2004;351:2730-2739
[6] Wilhalem MJ, Pratschke J, Laskowski IA, et al. Brain death and its impact on the donor heart-lesssons from animal model. H Heart Lung Transplant 2000;19:414-418
[7] Pennefether SH, Bullock RE, Mantle D, Dark JH. Use of Low Dose Arginine Vasopressin to Support Brain-Dead Organ Donors. Transplantation 1995; 59: 58.
[8] Kinoshita Y, Okamoto K, Yahata K, et al. Clinical and pathological changes of the heart in brain death maintained with vasopressin and epinephrine. Pathol Res Pract. 1990 Feb;186(1):173-9
[9] Iwai A, Sakano T, Uenishi M,et al. Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation. 1989 Oct;48(4):613-7.
[10] Conci F,Di Rienzo M, Castiglioni P. Blood pressure and heart rate variability and baroreflex sensitivity before and after brain death. J Neurol Neurosurg Psychiatry 2001;71:621–631
[11] Fukushima N, Shirakura R, Nakata S, et al. Failure of rapid autonomic augmentation of cardiac performance in transplanted hearts. Transplant Proc. 1998 Nov;30(7):3344-6. No abstract available.
[12] D'Amico TA, Buchanan SA, Lucke JC, et al. The preservation of cardiac function after brain death: a myocardial pressure-dimension analysis. Surg Forum 1990;41:277-9.
[13] Sakagoshi N, Shirakura R, Nakano S, et al. Serial changes in myocardial beta-adrenergic receptor after experimental brain death in dogs. J Heart Lung Transplant 1992;11:1054-8.
[14] Fukushima N, Sakagoshi N, Ohtake S, et al. Effects of exogenous adrenaline on the number of the beta-adrenergic receptors after brain death in humans. Transplant Proc 2002;34:2571-4.
[15] Young JB, Naftel DC, Bourge RC, et al., and the Cardiac Transplant Research Database Group Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: A multivariable, multiinstitutional report. J Heart Lung Transplant 1994; 13: 353-65.
[16] Grauhan O, Siniawski H, Dandel M, et al. Coronary atherosclerosis of the donor heart – impact on early graft failure. Eur J Cardiothorac Surg 2007;32 (4):634-8.
[17] Fukushima
[18] Musci M, Pasic M, Grauhan O,et al. Orthotopic heart transplantation with concurrent coronary artery bypass grafting or previous stent implantation. Z Kardiol 2004; 93: 971-4.
[19] Milano A, Livi U, Casula R, et al. Influence of marginal donors on early results after heart transplantation. Transplant Proc 1993; 25: 3158.
[20] Stoica SC, Satchithananda DK, Charman S, et al. Swanganz catheter assessment of donor hearts: outcome of organs with borderline hemodynamics. J Heart Lung Transplant 2002; 21: 615.
[21] Ranger GS. Antidiuretic hormone replacement therapy to prevent or ameliorate vasodilatory shock. Medical Hypotheses 59(3):337–340,2002
[22] Guesde R, Barrou B, Leblanc I, et al. Administration of desmopressin in brain-dead donors and renal function in kidney patients. Lancet 1998; 352: 1178.
[23] Marques RG, Rogers J, Chavin KD, et al. Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study. Transplant Proc 2004; 36: 1048.
[24] Zaroff JG, Rosengard BR, Armstrong et al. Maximizing Use of Organs Recovered from the Cadaver Donor: Cardiac Recommendations. J. Heart Lung Transplant 2002; 21: 1153.
[25] Hoefer D, Ruttmann-Ulmer E, Smits JM, Devries E, Antretter H, Laufer G. Donor hypo- and hypernatremia are predictors for increased 1-year mortality after cardiac transplantation. Transplant Int(E-pub)2009